Interferon-??-2b Plus Ribavirin
- 1 January 2002
- journal article
- Published by Springer Nature in Drugs
- Vol. 62 (3) , 507-556
- https://doi.org/10.2165/00003495-200262030-00009
Abstract
No abstract availableThis publication has 111 references indexed in Scilit:
- Reduced plasma transforming growth factor-β1 levels in patients with chronic hepatitis C after interferon-α therapy: association with regression of hepatic fibrosisJournal of Hepatology, 1999
- Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled studyJournal of Hepatology, 1996
- An Algorithm for the Grading of Activity in Chronic Hepatitis CHepatology, 1996
- Major Therapeutic Uses of InterferonsClinical Immunotherapeutics, 1995
- Interferon-α2a increases serum concentration of hyaluronic acid and type III procollagen aminoterminal propeptide in patients with chronic hepatitis B virus infectionDigestive Diseases and Sciences, 1994
- 2′,5′-Oligoadenylate Synthetase Activity as a Responsive Marker During Interferon Therapy for Chronic Hepatitis CJournal of Interferon Research, 1993
- Interferon-?? in Malignant and Viral DiseasesDrugs, 1993
- α-Interferon in the treatment of chronic viral hepatitis: effects on fibrogenesis serum markersJournal of Hepatology, 1993
- Antiviral actions of interferon interferon-regulated cellular proteins and their surprisingly selective antiviral activitiesVirology, 1991
- Differential effect of α-interferons on CD4- and CD8-positive lymphocytes in chronic hepatitis B virus carriersJournal of Hepatology, 1988